Professor Fiona Mulcahy
Professor, Clinical Medicine
Publications and Further Research Outputs
Peer-Reviewed Publications
Murphy PJ, Hevey D, O'Dea S, Ní Rathaille N, Mulcahy F. , Serostatus Disclosure, Stigma Resistance, and Identity Management Among HIV-Positive Gay Men in Ireland, Qual Health Res, 26, (11), 2016, p1459 - 1472
Murphy, P. Hevey, D., O'Shea, S., Ni Rathaille, N., & Mulcahy, F., Optimism, community attachment and serostatus disclosure among HIV-positive men who have sex with men, AIDS Care, 27, 2015, p431 - 435
Muldoon EG, Walsh A, Crowley B, Mulcahy F, Treponema pallidum azithromycin resistance in Dublin, Ireland., Sexually transmitted diseases, 39, (10), 2012, p784-6
Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, Gatell J, d'Arminio Monforte A, Phillips A, Lundgren JD, Kirk O, Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy., AIDS (London, England), 26, (3), 2012, p315-23
Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon D, Paton NI, Prineas RJ, Neaton JD, Inflammation, coagulation and cardiovascular disease in HIV-infected individuals., PloS one, 7, (9), 2012, pe44454
Cozzi-Lepri A, Paredes Phillips AN, Clotet B, Kjaer J, Von Wyl V, Kronborg G, Castagna A, Bogner JR, Lundgren JD, The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*., HIV medicine, 13, (1), 2012, p62-72
Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, Delpech V, Phillips AN, Projected life expectancy of people with HIV according to timing of diagnosis., AIDS (London, England), 26, (3), 2012, p335-43
Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A, Gatell J, Fisher M, Trocha H, Rakhmanova A, Lundgren JD, The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression., Antiviral therapy, 17, (7), 2012, p1291-300
Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M, Reiss P, El-Sadr W, Monforte AD, Friis-Møller N, Lundgren JD, Law MG, Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study., Journal of the International AIDS Society, 15, (2), 2012, p17426
May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA, Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics., International journal of epidemiology, 41, (6), 2012, p1807-20
Mocroft A, Neuhaus J, Peters L, Ryom L, Bickel M, Grint D, Koirala J, Szymczak A, Lundgren J, Ross MJ, Wyatt CM, Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults., PloS one, 7, (7), 2012, pe40245
Worm SW, Kamara DA, Reiss P, Fontas E, De Wit S, El-Sadr W, D'Arminio Monforte A, Law M, Phillips A, Ryom L, Dabis F, Weber R, Sabin C, Lundgren JD, Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke., The Journal of infectious diseases, 205, (4), 2012, p535-9
Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study., D Podlekareva, J Reekie, A Mocroft, M Losso, A Rakhmanova, E Bakowska, IA Karpov, J Lazarus, J Gatell, JD Lundgren, O Kirk., BMC Infect Dis. , 12, (1), 2012
Muldoon EG, Mooka B, Reidy D, O'Dea S, Clarke S, Courtney G, Lyons F, Bergin C, Mulcahy F, Long-term neurological follow-up of HIV-positive patients diagnosed with syphilis., International journal of STD & AIDS, 23, (9), 2012, p676-8
Cozzi-Lepri A, Prosperi MC, Kjær J, Dunn D, Paredes R, Sabin CA, Lundgren JD, Phillips AN, Pillay D, Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score., PloS one, 6, (11), 2011, pe25665
Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S, Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)., HIV medicine, 12, (4), 2011, p219-27
Bannister WP, Cozzi-Lepri A, Kjær J, Clotet B, Lazzarin A, Viard JP, Kronborg G, Duiculescu D, Beniowski M, Machala L, Phillips A, Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy., The Journal of antimicrobial chemotherapy, 66, (4), 2011, p901-11
Fox ZV, Cozzi-Lepri A, D'Arminio Monforte A, Karlsson A, Phillips AN, Kronborg G, Kjaer J, Clotet B, Lundgren JD, Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDA., Antiviral therapy, 16, (5), 2011, p781-5
Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C, Friis-Møller N, Weber R, Mercie P, Pradier C, El-Sadr W, Kirk O, Lundgren J, Law M, Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)., HIV medicine, 12, (7), 2011, p412-21
Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, Domingo P, Mocroft A, Lundgren JD, Kirk O, Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors., AIDS (London, England), 25, (12), 2011, p1505-13
Worm SW, Kamara DA, Reiss P, Kirk O, El-Sadr W, Fux C, Fontas E, Phillips A, D'Arminio Monforte A, De Wit S, Petoumenos K, Friis-Møller N, Mercie P, Lundgren JD, Sabin C, Elevated triglycerides and risk of myocardial infarction in HIV-positive persons., AIDS (London, England), 25, (12), 2011, p1497-504
Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M, Gatell J, Pedersen C, Bogner JR, Lundgren JD, Mocroft A, Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study., AIDS (London, England), 25, (10), 2011, p1305-15
Kowalska JD, Friis-Møller N, Kirk O, Bannister W, Mocroft A, Sabin C, Reiss P, Gill J, Lewden C, Phillips A, D'Arminio Monforte A, Law M, Sterne J, De Wit S, Lundgren JD, The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology., Epidemiology (Cambridge, Mass.), 22, (4), 2011, p516-23
Esser S, Haberl A, Mulcahy F, Gölz J, Lazzarin A, Teofilo E, Vera J, Körber A, Staszewski S, Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study., European Journal of Medical Research, 16, (10), 2011, p427-36
Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J, Sambatakou H, Pedersen C, Lundgren JD, Kirk O, A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study., HIV clinical trials, 12, (2), 2011, p109-17
DA Kamara, SW Worm, P Reiss, M Rickenbach, A Phillips, O Kirk, AD Monforte, M Bruyand, M Law, S De Wit, C Smith, C Pradier, JD Lundgren, C Sabin, The impact of fasting on the interpretation of triglyceride levels for predicting myocardial infarction risk in HIV-positive individuals: the D:A:D study., The Journal of infectious diseases, 204, (4), 2011, p521-5
Kieran J, Dillon A, Farrell G, Jackson A, Norris S, Mulcahy F, Bergin C, High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic., International journal of STD & AIDS, 22, (10), 2011, p571-6
Bohlius J, Schmidlin K, Boué F, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Paparizos V, Miro JM, Obel N, Prins M, Chêne G, Egger M, HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes., Blood, 117, (23), 2011, p6100-8
Soriano V, Grint D, d'Arminio Monforte A, Horban A, Leen C, Poveda E, Antunes F, de Wit S, Lundgren J, Rockstroh J, Peters L, Hepatitis delta in HIV-infected individuals in Europe., AIDS (London, England), 25, (16), 2011, p1987-92
Kennedy A, Hennessy M, Bergin C, Mulcahy F, Hopkins S, Spiers JP, Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients., Antiviral therapy, 16, (8), 2011, p1237-47
Paredes R, Puertas MC, Bannister W, Kisic M, Cozzi-Lepri A, Pou C, Bellido R, Betancor G, Bogner J, Gargalianos P, Bánhegyi D, Clotet B, Lundgren J, Menéndez-Arias L, Martinez-Picado J, A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy., The Journal of infectious diseases, 204, (5), 2011, p741-52
Reekie J, Gatell JM, Yust I, Bakowska E, Rakhmanova A, Losso M, Krasnov M, Francioli P, Kowalska JD, Mocroft A, Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata., AIDS (London, England), 25, (18), 2011, p2259-68
Reekie, J, Reiss, P, Ledergerber, B, Sedlacek, D, Parczewski, M, Gatell, J, Katlama, C, Fatkenheuer, G, Lundgren, JD, Mocroft, A, A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study, HIV MEDICINE, 12, (5), 2011, p259-68
Fiona Mulcahy, The EuroSIDA Study Group, History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change, HIV Medicine, 2010
Fiona Mulcahy, The EuroSIDA Study Group, Estimated average annual rate of change of CD4 counts in patients on combination antiretroviral therapy, Antiviral Therapy, 2010
Fiona Mulcahy, The EuroSIDA Study Group, Predictors of hepatitis B virus (HBV) genotype and viremia in HIV-infected patients with chronic hepatitis B in Europe, Journal of Antimicrobial Chemotherapy, 2010
Fiona Mulcahy, The SWEET (Simplification With Easier Emtricitabine Tenofovir) group UK, A randomized comparative trial of continued Zidovudine/Lamivudine or replacement with Tenofovir Disoproxil Fumarate/Emtricitabine in Efavirenz treated HIV-1 infected individuals, Journal of Acquired Immune Deficiency Syndromes, 51, (5), 2009, p562-568
M van Luin, WP Bannister, A Mocroft, P Reiss, G Di Perri, G Peytavin, J Molto, A Karlson, A Castagna, M Beniowski, JD Lundgren, DM Burger; the EuroSIDA study group (Includes Mulcahy, F.) , Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in EuroSIDA., Antiviral Therapy, 14, (1), 2009, p75-83
Fiona Mulcahy, The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group, Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy, AIDS, 23, (15), 2009, p2029-2037
Fiona Mulcahy and the EuroSIDA Study Group, Hepatitis C Virus (HCV) Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1 Infected Patients with Maximum Virologic Suppression., Journal of Acquired Immune Deficiency Syndromes, 50, (5), 2009, p457-463
Fiona Mulcahy, The INSIGHT-ESPRIT Study Group, Interleukin - 2 therapy in patients with HIV infection, The New England Journal of Medicine, 361, (16), 2009, p1548-1559
Fiona Mulcahy, The Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study, Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study, Diabetes Care, 32, (3), 2009, p474-480
Fiona Mulcahy, The EuroSIDA Study Group, Rate of Accumulation of Thymidine Analogue Mutations in Patients Continuing to Receive Virologically Failing Regimens Containing Zidovudine or Stavudine: Implications for Antiretroviral Therapy Programs in Resource-Limited Settings, The Journal of Infectious Diseases, 200, (5), 2009, p687-697
A. Loy, Mulcahy, F, Review of Overview of Genital Warts , Modern Medicine, 2, (29), 2009, p36-40
Fiona Mulcahy, The When To Start Consortium, Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies, Lancet, 373, (9672), 2009, p1352-1363
Fiona Mulcahy, The Nevirapine Toxicity Multicohort Collaboration., Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy, AIDS, 23, (13), 2009, p1689-1699
Fiona Mulcahy, The Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study, Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). , Circulation, 119, (6), 2009, p805 - 811
A Mocroft, O Kirk, P Aldins, A Chies, A Blaxhult, N Chentsova, N Vetter, F Dabis, J Gatell and JD Lundgren, for the EuroSIDA study group. (Includes Mulcahy, F.) , Loss to follow-up in an international, multicentre observational study. , HIV Medicine, 9, (1), 2009, p261-269
A Cozzi-Lepri, AN Phillips, B Clotet, A Mocroft, L Ruiz, O Kirk, A Lazzarin, A Wiercinska-Drapalo, A Karlsson, JD Lundgren for the EuroSIDA Study Group. (Includes Mulcahy, F.), Detection of HIV drug resistance during antiretrovrial treatment and clinical progression in a large European cohort study., AIDS, 22, (16), 2008, p2187-2198
V Soriano, A Mocroft, J Rockstroh, B Ledergerber, B Knysz, S Chaplinskas, L Peters, A Karlsson, C Katlama, C Toro, B Kupfer, M Vogel and J Lundgren, for the EuroSIDA Study Group. (Includes Mulcahy, F.) , Spontaneous viral clearance, viral load and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe., Journal of Infectious Diseases, 198, (9), 2008, p1337-1344
Smith CJ, Olsen CH, Mocroft A, Viard JP, Staszewski S, Panos G, Staub T, Blaxhult A, Vetter N, Lundgren JD..Results from the EuroSida Study Group (includes Mulcahy F), The role of antiretroviral therapy on the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study. , AIDS, 22, (1), 2008, p47-56
D Podlekareva, W Bannister, A Mocroft, L Abrosimova, I Karpov, JD Lundgren, O Kirk for the EuroSIDA study group. (Includes Mulcahy, F.), The EuroSIDA study: regional differences in HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe - a review of published results. , Cent Eur J Public Health. , 16, (3), 2008, p99-105
CJ Smith, A Mocroft, JD Lundgren; EuroSIDA Study Group. (Includes Mulcahy, F.), Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy., AIDS, 22, (8), 2008, p997-998
WP Bannister, A Cozzi-Lepri, B Clotet, A Mocroft, J Kjær, P Reiss, V von Wyl, A Lazzarin, C Katlama, AN Phillips, L Ruiz, JD Lundgren and the EuroSIDA study group. (Includes Mulcahy, F.) , Transmitted drug resistance and association with virological and CD4 cell count response to combination antiretroviral therapy in EuroSIDA., J Acquir Immune Defic Syndr., 48, (3), 2008, p324-333
J Reekie, A Mocroft, H Sambatakou, L Machala, A Chiesi, J van Lunzen, N Clumeck, O Kirk, B Gazzard, JD Lundgren for the EuroSIDA study group. (Includes Mulcahy, F.), Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?, aids, 226, (17), 2008, p2381-2390
Kowalska JD, Mocroft A, Blaxhult A, Colebunders R, van Lunzen J, Podlekareva D, Hansen AB, Machala L, Yust I, Benfield T; for the EuroSIDA Study Group. (includes Mulcahy F), Current haemoglobin levels are more predictive of disease progression than haemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV-1 infection. , AIDS Research and Human Retroviruses. , 23, (10), 2008, p1183-1188
Shea DO, Tuite H, Farrell G, Codd M, Mulcahy F, Norris S, Bergin C, Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV / HIV co-infected individuals., Journal of Viral Hepatitis, 15, (7), 2008, p482-489
K Deforche, A Cozzi-Lepri, K Theys, B Clotet, RJ Camacho, J Kjær, K Van Laethem, AN Phillips, Y Moreau, JD Lundgren, and A-M Vandamme on behalf of the EuroSID Study Group. (Includes Mulcahy, F.) , Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response. , Antiviral Therapy, 13, (3), 2008, p399-407
WP Bannister, N Friis-Møller, A Mocroft, J-P Viard, J van Lunzen, O Kirk, P Gargalianos, D Bánhegyi, A Chiesi, JD Lundgren, and the EuroSIDA study group. (Includes Mulcahy, F.) , Incidence of abacavir hypersensitivity reactions in EuroSIDA. , Antiviral Therapy, 13, (5-6), 2008, p687-696
A Mocroft, A Horban, B Clotet, A d'Arminio Monforte, JR Bogner, P Aldins, T Staub, F Antunes, C Katlama, JD Lundgren for the EuroSIDA study group. (Includes Mulcahy, F.) , Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999, HIV Medicine, 9, (1), 2008, p41-46
Bannister, W.P., Ruiz, L., Cozzi-Lepri, A., Mocroft, A., Kirk, O., Staszewski, S., Loveday, C., Mulcahy, F. (...), Reekie, J., Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA , AIDS, 22, (3), 2008, p367-376
Holmes A, McMenamin M, Mulcahy F, Bergin C., Thalidomide therapy for the treatment of hypertrophic herpes simplex virus-related genitalis in HIV-infected individuals., Clin Infect Dis., 44, (11), 2007, pe96-9
A Cozzi-Lepri, AN Phillips, J Martinez-Picado, A d'Arminio Monforte, C Katlama, A-B Eg Hansen, A Horban, J Bruun, B Clotet and J Lundgren, Rate of accumulation of thymidine analogue mutations in patients left on virologically failing regimens containing zidovudine or stavudine. , XVI International HIV Drug Resistance Workshop, Barbados, June 2007, 2007
O'Connor GM, Holmes A, Mulcahy F, Gardiner CM., Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function, Clin Immunol. , 124, (3), 2007, p277-83
A Mocroft, O Kirk, J Gatell, P Reiss, P Gargalianos, K Zilmer, M Beniowski, JP Viard, S Staszewski, JD Lundgren , Detection of chronic renal failure (CRF) amon HIV-patients within the EuroSIDA Study. , 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, February 2007, 2007
K Deforche, A Cozzi-Lepri, K Theys, B Clotet, R Camacho, J Kjaer, K Van Laethem, AN Phillips, Y Moreau, JD Lundgren and A-M Vandamme , Proof-of-Principle Evaluation of Predictive Performance for Therapy Outcome of Baseline Estimated Fitness and Genetic Barrier towards Resistance in a Clinical Cohort of HIV-1 Treated Patients., XVI International HIV Drug Resistance Workshop, Barbados, June 2007, 2007
Mocroft A, Ledergerber B, Zilmer K, Kirk O, Hirschel B, Viard JP, Reiss P, Francioli P, Lazzarin A, Machala L, Phillips AN, Lundgren JD; EuroSIDA study group and the Swiss HIV Cohort Study. (includes Mulcahy F), Short term clinical disease progression in HIV-1 positive patients taking combination antiretroviral therapy: The EuroSIDA risk-score., AIDS, 21, (14), 2007, p1867-1875
Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD; EuroSIDA study group. (includes Mulcahy F), Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. , HIV Medicine, 8, (2), 2007, p96-104
ZV Fox, AM Geretti, B Clotet, A Cozzi-Lepri, T Hill, H Green, CA Sabin, B Ledergerber, JD Lundgren and AN Phillips, Association between Resistance and CD4 Count Change in Patients on ART with Ongoing Viraemia., EuroSIDA Fall 2007, XVI International HIV Drug Resistance Workshop, Barbados, June 2007, 2007
Ceccherini-Silberstein F, Cozzi-Lepri A, Ruiz L, Mocroft A, Phillips AN, Olsen CH, Gatell JM, Gunthard HF, Reiss P, Perno CF, Clotet B, Lundgren JD; EuroSIDA Study Group. (includes Mulcahy F), Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue based regimens in ART-naïve and experienced patients., Journal of Infectious Diseases, 196, (8), 2007, p1180-1190
Lactic Acidosis International Study Group, Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy, AIDS , 21, (18), 2007, p2455-2464
A Mocroft, AN Phillips, J Gatell, B Ledergerber, M Fisher, N Clumeck, M Losso, A Lazzarin, G Fätkenheuer, JD Lundgren, Normalisation of CD4 count in HIV-infected patients with maximal virological suppression (<50 copies/ml) taking combination antiretroviral therapy., 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, February 2007, 2007
Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S; INITIO Trial International Coordinating Committee. (includes Mulcahy F) , Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection, AIDS, 21, (18), 2007, p2445-2453
A. Mocroft, A. Horban, N. Clumeck, H.J. Stellbrink, d'Arminio A. Monforte, K. Zilmer, O. Kirk, J. Gatell, A.N. Phillips, J.D. Lundgren, Comparison of Single and Boosted Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor-Containing cART Regimens in Antiretroviral-Naïve Patients Starting cART After January 1, 2000 , HIV Clinical Trials, 7, (6), 2007, p271-284
Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, Losso M, Lazzarin A, Fatkenheuer G, Lundgren JD; EuroSIDA study group. (includes Mulcahy F), Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. , Lancet Oncology, 370, (9585), 2007, p407-413
Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD. EuroSida Study Group (includes Mulcahy F), Chronic renal failure among HIV-1-infected patients. , AIDS, 21, (9), 2007, p1119-1127
INITIO Trial International Co-ordinating Committee, Yeni P, Cooper DA, Aboulker JP, Babiker AG, Carey D, Darbyshire JH, Floridia M, Girard PM, Goodall RL, Hooker MH, Mijch A, Meiffredy V, Salzberger B., Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial., Lancet, 368, (9532), 2006, p287-98
Z Fox, M Gisslen, B Gazzard, J Kjær, H Nielsen, M Youle, I Cassetti, AN Phillips, UB Dragsted, and JD Lundgren , The ability of four genotypic resistance algorithmis for predicting HIV-RNA responses 4-24 weeks after initiating a boosted PI-containing regimen., 4th European Drug Resistance Workshop, Monte Carlo, March 2006, 2006
Kaul P, Walmsley S, Mulcahy F., Antiretroviral rounds. A patient with multiple resistance mutations and a history of nonadherence., AIDS Clin Care. , 18, (12), 2006, p110-1
Mocroft A, Neaton J, Bebchuk J, Staszewski S, Antunes F, Knysz B, Law M, Phillips AN, Lundgren JD; EuroSIDA Study Group (includes Mulcahy F) ESPRIT Study Group, The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era. , Clinical Trials, 3, (2), 2006, p119-132
Bannister Wendy P; Ruiz Lidia; Loveday Clive; Vella Stefano; Zilmer Kai; Kjaer Jesper; Knysz Brygida; Phillips Andrew N; Mocroft Amanda; EuroSida Study Group (includes Mulcahy F), HIV-1 subtypes and response to combination antiretroviral therapy in Europe., Antiviral therapy , 11, (6), 2006, p707-715
Bannister WP, Kirk O, Gatell JM, Knysz B, Viard JP, Mens H, Monforte AD, Phillips AN, Mocroft A, Lundgren JD; EuroSIDA Study Group.(includes Mulcahy F), Regional changes over time in initial virological response rates to combination antiretroviral therapy across Europe. , Journal of Acquired Immune Deficiency Syndromes, 42, (2), 2006, p229-237
A Mocroft, B Ledergerber, K Zilmer, O Kirk, B Hirschel, JP Viard, P Reiss, P Francioli, A Lazzarin, L Machala, AN Phillips, JD, Short term clinical disease progression in HIV-1 positive patients taking combination antiretroviral therapy: The EuroSIDA risk-score., EuroSIDA Newsletter, The XVI International AIDS Conference, Toronto, August 2006, 2006
A Mocroft, J Rockstroh, J Gasiorowski, F Antunes, G Panos, A d"Arminio Monforte, A Rakhmanova,, AN Phillips, JD Lundgren, Risk of discontinuation of nevirapine due to toxicitites in antiretroviral naive and experienced patients with high and low CD4 counts. For the EuroSIDA study group. , The XVI International AIDS Conference , Toronto, August 2006, 2006
Lyons F, Hopkins S, Kelleher B, McGeary A, Sheehan G, Geoghegan J, Bergin C, Mulcahy FM, McCormick PA., Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy., HIV Med. , 7, (4), 2006, p255-60.
S.L. Pett, H. Wand, M.G. Law, R. Arduino, J.C. Lopez, B. Knysz, L.C. Pereira, S. Pollack, P. Reiss, G. Tambussi, Evaluation of Subcutaneous Proleukin (Interleukin-2) in a Randomized International Trial (ESPRIT): Geographical and Gender Differences in the Baseline Characteristics of Participants, HIV Clinical Trials, 7, (2), 2006, p70-85
WP Bannister, AN Phillips, B Clotet, P Reiss, B Ledergerber, A Lazzarin, C Katlama, A Cozzi-Lepri, L Ruiz, JD Lundgren, Genotypic resistance profile before initiation of cART and association with virological and clinical outcome in EuroSIDA., Eurosida Newsletter, The XVI International AIDS Conference, Toronto, August 2006, 2006
Lyons F, Butler K, Coulter Smith S, Mulcahy F., National guidelines for the management of HIV-1 in pregnancy., Ir Med J. , 99, (5), 2006, p152-4
Podlekareva D, Mocroft A, Dragsted UB, Ledergerber B, Beniowski M, Lazzarin A, Weber J, Clumeck N, Vetter N, Phillips A, Lundgren JD; EuroSIDA study group., Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4 cell counts in the EuroSIDA study., J Infect Dis, 13th Conference on Retroviruses and Opportunistic Infections, Denver, February 2006, 194, (5), 2006, pp633-641
Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD., Liver related deaths among persons infected with the human immunodeficiency virus: the D:A:D Study, Archives of Internal Medicine, 166, (15), 2006, p1632-1641
Mocroft Amanda; Rockstroh Jurgen; Soriano Vincent; Kirk Ole; Viard Jean-Paul; Caplinskas Saulius; Gasiorowski Jacek; Chiesi Antonio; Phillips Andrew N; Lundgren Jens D; EuroSIDA Study Group (includes Mulcahy F), Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C., Scandinavian Journal of infectious diseases, 38, (11-12), 2006, p1092-1097
Hopkins S, Lambourne J, Farrell G, McCullagh L, Hennessy M, Clarke S, Mulcahy F, Bergin C., Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals., HIV Med. , 7, (4), 2006, p248-54.
Mocroft A, Phillips AN, Ledergerber B, Katlama C, Chiesi A, Goebel FD, Knysz B, Antunes F, Reiss P, Lundgren JD. EuroSida Study Group (includes Mulcahy F), Relationship between antiretrovirals used as part of a cART regimen and CD4 count increases in patients with suppressed viremia. , AIDS, 20, (8), 2006, p1141-1150
A Cozzi-Lepri, L Ruiz, F Ceccherini-Silberstein, A Mocroft, A Phillips, J Gatell, B Ledergerber, P Reiss, B Clotet, JD Lundgren and the EuroSIDA Study group., Mutation at reverse transcriptase codon 214 is antagonist to thymidine analogue mutations type 2 profiles and predicts virological response to thymidine analogue-containing cART regimens only if TAM type 1 profiles concomitantly detected., 13th Conference on Retroviruses and Opportunistic Infections, , Denver, February 2006, 2006
Puoti M, Cozzi-Lepri A, Paraninfo G, Arici C, Moller NF, Lundgren JD, Ledergerber B, Rickenbach M, Suarez-Lozano I, Garrido M, Dabis F, Winnock M, Milazzo L, Gervais A, Raffi F, Gill J, Rockstroh J, Ourishi N, Mussini C, Castagna A, De Luca A, Monforte A; HBV-HIV International Intercohort Study Group. EuroSida Study Group (includes Mulcahy F), Impact of lamivudine on the risk of liver related death in 2,041 HbsAg - and HIV positive individuals: result from an inter-cohort analysis., Antiviral Therapy , 11, (5), 2006, p567-574
Treacy A, Lyons F, Mulcahy F., Opportunistic cervical screening at a sexual health clinic., Ir Med J. , 99, (7), 2006, p198-9.
May MT, Sterne JA, Costagliola D, Sabin CA, Phillips AN, Justice AC, Dabis F, Gill J, Lundgren J, Hogg RS, de Wolf F, Fätkenheuer G, Staszewski S, d'Arminio Monforte A, Egger M; Antiretroviral Therapy (ART) Cohort Collaboration (includes Mulcahy F), HIV treatment response and prognosis in Europe and north America in the first decade of highly active antiretroviral therapy: a collaboration analysis., Lancet., 368, (9534), 2006, p451-458
Podlekareva D, Mocroft A, Dragsted UB, Ledergerber B, Beniowski M, Lazzarin A, Weber J, Clumeck N, Vetter N, Phillips A, Lundgren JD; EuroSIDA study group.(includes Mulcahy F), Factors associated with development of opportunistic infections in HIV-1 infected adults with high CD4 cell counts, Journal of Infectious Diseases, 194, (1), 2006, p663-641
A Mocroft, J Rockstroh, V Soriano, B Ledergerber, O Kirk, E Vinogradova, P Reiss, C Katlama, AN Phillips, JD Lundgren for the EuroSIDA study group. (includes Mulcahy F), Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?, Antivir. Ther., 10, (7), 2005, p779 - 790
S Hopkins, C Coleman, M Kelleher, S Keating, S Clarke, B O'Connell, F Mulcahy, C Bergin, Increasing resistance to Ciprofloxacin among isolates of Neiserria Gonorrhoea in Dublin, IMJ, 98, (1), 2005, p208 - 208
A Mocroft, V Soriano, J Rockstroh, P Reiss, O Kirk, S de Wit, J Gatell, B Clotet, AN Phillips, JD Lundgren for the EuroSIDA study group. (includes Mulcahy F), Is there evidence for an increase in the death-rate from liver-related disease in patients with HIV?, AIDS, 19, (18), 2005, p2117 - 2125
E Girardi, CA Sabin, A d'Arminio Monforte, B Hogg, AN Phillips, MJ Gill, F Dabis, P Reiss, O Kirk, E Bernasconi, S Grabar, A Justice, S Staszewski, G Fatkenheuer, JA Sterne; Antiretroviral Therapy Cohort Collaboration. (includes Mulcahy F), Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America, Clin Infect Dis., 41, (12), 2005, p1772 - 1782
D Konopnicki, A Mocroft, S De Wit, F Antunes, B Ledergerber, C Katlama, K Zilmer, S Vella, O Kirk, and JD Lundgren for the EuroSIDA Group. (includes Mulcahy F), Hepatitis B and HIV: prevalence, AIDS progression, response to HAART and increased mortality in the EuroSIDA cohort, AIDS, 19, (6), 2005, p593 - 601
A Mocroft, AN. Phillips, V Soriano, J Rockstroh, A Blaxhult, C Katlama, A Boron-Kaczmarska, L Viksna, O Kirk, JD Lundgren (includes Mulcahy F), Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection, AIDS Res Hum Retroviruses, 21, (9), 2005, p743 - 752
R Thiebaut, WM El-Sadr, N Friis-Moller, M Rickenbach, P Reiss, AD Monforte, L Morfeldt, E Fontas, O Kirk, S De Wit, G Calvo, MG Law, F Dabis, CA Sabin, JD Lundgren; Data Collection of Adverse events of anti-HIV Drugs Study Group. (includes Mulcahy F), Predictors of hypertension and changes of blood pressure in HIV-infected patients, Antivir Ther., 10, (7), 2005, p811 - 823
A Mocroft, C Oancea, J van Lunzen, P Vanhems, D Banhegyi, A Chiesi, E Vinogradova, S Maayan, AN Phillips and J Lundgren. (includes Mulcahy F), Decline in oesophageal candidiasis and use of antimycotics in patients with HIV, Am J Gastroenterol., 100, (7), 2005, p1446 - 1454
J Rockstroh, A Mocroft, V Soriano, C Tural, M Losso, A Horban, O Kirk, A Phillips, B Ledergerber, J Lundgren for the EuroSIDA study group. (includes Mulcahy F), Influence of Hepatitis C o¬n HIV Disease Progression and Response to Antiretroviral Therapy, J Infect Dis., 192, (6), 2005, p992 - 1002
Holkmann Olsen C, Gatell J, Ledergerber B, Katlama C, Friis-Møller N, Weber J, Horban A, Staszewski S, Lundgren J, Phillips A. (includes Mulcahy F), Risk of AIDS and death at given HIV-RNA and CD4 count levels, according to specific antiretroviral drugs in the regimen, AIDS, 19, 2005, p319 - 330
Lyons F, Prendiville W, Mulcahy F., Cervical Disease in HIV 1 positive women: a review, Intl J Std & AIDS, 15, 2004, p89 - 93
Phillips AN, Ledergerber B, Horban A, Reiss P, Chiesi A, Kirk O, Mulcahy F, Fisher M, Machala L, Lundgren JD; EuroSIDA Study Group. (includes Mulcahy F), Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression, AIDS, 18, (13), 2004, p1795 - 1804
d'Arminio Monforte A, Cinque P, Mocroft A, Goebel FD, Antunes F, Katlama C, Justesen US, Vella S, Kirk O, Lundgren J; EuroSIDA Study Group. (includes Mulcahy F), Changing incidence of central nervous system diseases in the EuroSIDA cohort, Ann Neurol., 55, (3), 2004, p320 - 328
Mocroft A, d'Arminio Monforte A, Kirk O, Johnson M, Friis-Moller N,, Changes in hospital admissions across Europe:1994-2003. Results from the EuroSIDA study, HIV Med., 5, (6), 2004, p437 - 447
Mocroft A, Kirk O, Clumeck N, Gargalianos P, Trocha H, Chentsova N, Antunes F, Stellbrink H-J, Phillips AN, Lundgren JD for the EuroSIDA study group. (includes Mulcahy F), The Changing pattern of Kaposi"s sarcoma in patients with HIV - 1994-2003. The EuroSIDA Study, Cancer, 100, 2004, p2644 - 2654
d'Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Lundgren JD, Friis-Moller N; Writing Committee of the D:A:D: Study Group. (includes Mulcahy F), Cardio- and Cerebrovascular Events in HIV-Infected Persons, AIDS, 18, (13), 2004, p1811 - 1817
Lukhart S, Godornes C, Moline B, Sonnett P, Hopkins S, Engleman J, Mitchell SJ Rompalo A, Marra C, Klausner J, Mulcahy F., Marolide resistance in treponema pallidum in the United States and Ireland, N England J Med, 351, (2), 2004, p154 - 158
Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, Blaxhult A, Phillips AN, Lundgren J; for the EuroSIDA study group. (includes Mulcahy F), Causes of death in HIV infection:the key determinant to define the clinical response to anti-HIV therapy, AIDS, 18, (17), 2004, p2333 - 2337
Phillips AN, Ledergerber B, Horban A, Reiss P, Chiesi A, Kirk O, Mulchany F, Fisher M, Machala L, Lundgren JD; EuroSIDA Study Group. (includes Mulcahy F), Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression. , AIDS, 18, (3), 2004, p1795-1804
Mocroft A, Ledergerber B, Viard JP, Staszewski S, Murphy M, Chiesi A, Horban A, Hansen AB, Phillips AN, Lundgren JD; EuroSIDA Study Group. (includes Mulcahy F), Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group, J Infect Dis., 190, (11), 2004, p1947 - 1956
Ryan M, Merry C, Ryan C, Bennett K, Heerey A, McGowan B, Mulcahy F, Barry M., Population based study of the cost of inpatient care for HIV infected individuals in an Irish teaching hospital, IMJ, 97, (7), 2004, p200 - 202
Cabrera C, Cozzi-Lepri A, Phillips AN, Loveday C, Kirk O, Ait-Khaled M, Reiss P, Kjær J, Ledergerber B, Lundgren JD, Clotet B, Ruiz L; EuroSIDA study group. (includes Mulcahy F), Baseline Resistance and Virologic Outcome in Patients with Virologic Failure who start a Regimen Containing Abacavir: EuroSIDA Study, Antivir Ther., 9, (5), 2004, p787 - 800
Dragsted UB, Mocroft A, Vella S, Viard JP, Hansen AE, Panos G, Mercey D, Machala L, Horban A, and Lundgren JD; EuroSIDA study group. (includes Mulcahy F), Predictors of immunological failure after initial response to HAART in HIV-1 infected adults: a EuroSIDA study, J Infect Dis., 190, (1), 2004, p148 - 155
EuroSida Study Group. (includes Mulcahy F), Changes in hospital admission across Europe: 1995 - 2003, HIV Medicine, 5, 2004, p437 - 447
Fontas E, van Leth F, Sabin CA, Friis-Moller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, Reiss P; D:A:D Study Group (includes Mulcahy F), Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?, J Infect Dis., 189, (6), 2004, p1056 - 1074
Phillips AN, Ledergerber B, Lundgren JD, Hogg B, d'Arminio Monforte A, Castelli f, Walker S, Staszewski S, Thiébaut R, Gazzard B, Saag M, Petoumenos K, Johnson M, Scullard G, Gill J, James I, Fisher M, Mussini C, Klein M, Costagliola D. (includes Mulcahy F), Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound. Collaboration of HIV Cohorts, writting committee, J Infect Dis., 190, 2004, p675 - 687
Yust I, Fox Z, Burke M, Johnson AM, Tuner D, Mocroft A, Katlama C, Ledergerber B, Reiss P, Kirk O, for the EuroSIDA study. (includes Mulcahy F), Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe. A EuroSIDA study, 1994-2000, Eur J Clin Microbiol Infect Dis., 23, (7), 2004, p550 - 559
Kirk O, Mocroft A and Lundgren JD for the EuroSIDA study. (includes Mulcahy F), Reduction af aids og dødsrater i EuroSIDA-studiet. Et observationsstudie, Ugeskrift Laeger, 166, (26-31), 2004, p2571 - 2576
Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration. (includes Mulcahy F), Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes, Lancet, 364, (9428), 2004, p51 - 62
DAD Study Group includes Dr Fiona Mulcahy, Lipid Profiles in HIV infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles ?, The Journal of Infectious Diseases, 189, (6), 2004
Alessandro Cozzi-Lepri, Andrew N Phillips, Veronica Miller and EuroSida Study Group ( includes Mulcahy F), Changes in viral load in people with virological failure who remain on the same HAART regimen, Antiviral Therapy, 8, 2003, p127 - 136
Hennessy M., Clarke S., Spiers J.P., Kelleher D., Mulcahy F., Hoggard P., Back D., Barry M., Intracellular accumulation of Nelfinavir and its relationship to P-glycoprotein Expression and function in HIV infected patients, Antivir Ther., 8, (3), 2003, p191 - 198
Clarke S., Mulcahy F., Whats new for IDUs with HIV infection?, Sex Trans Infect, 79, (2), 2003, p80 - 83
The Data Collection on adverse events of anti HIV drugs (DAD Study Group. , Combination Antiretroviral therapy and the risk of myocardial infarction, N Engl J Med, 349, 2003, p1993 - 2003
M Law, N Friis-Moller, R Weber, ( includes Mulcahy F), Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study, HIV Medicine, 4, 2003, p1 - 10
Clarke S, Delamere S, McCullagh L, Hoskins S, Bergin C, Mulcahy F, Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users, HIV Med, 4, (1), 2003, p33 - 37
HENNESSY, M, KELLEHER, D, SPIERS, JP, BARRY, M, KAVANAGH, P, BACK, D, MULCAHY, F, FEELY, J, ST JOHN'S WORT INCREASES EXPRESSION OF P-GLYCOPROTEIN: IMPLICATIONS FOR DRUG INTERACTIONS, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 53, 2002, p75 - 82
CLARKE, S, MULCAHY, F, BERGIN, C, REYNOLDS, H, BOYLE, N, BARRY, M, BACK, DJ, ABSENCE OF OPIOID WITHDRAWAL SYMPTOMS IN PATIENTS RECEIVING METHADONE AND THE PROTEASE INHIBITOR LOPINAVIR-RITONAVIR, CLINICAL INFECTIOUS DISEASES, 34, 2002, 1143 - 1145
BOYLE, BM, SULLIVAN, DJ, FORKIN, C, MULCAHY, F, KEANE, CT, COLEMAN, DC, CANDIDA DUBLINIENSIS CANDIDAEMIA IN AN HIV-POSITIVE PATIENT IN IRELAND, INTERNATIONAL JOURNAL OF STD & AIDS, 13, 2002, p55 - 57
RING, M, BOLGER, N, ODONNELL, M, MALKIN, A, BERMINGHAM, N, AKPAN, E, MULCAHY, F, TURNER, MJ, GRIFFIN, M, OLEARY, JJ, EVALUATION OF LIQUID-BASED CYTOLOGY IN CERVICAL SCREENING OF HIGH-RISK POPULATIONS: A SPLIT STUDY OF COLPOSCOPY AND GENITO-URINARY MEDICINE POPULATIONS, CYTOPATHOLOGY, 13, 2002, p152 - 159
NI RIAIN, A, STEWART, M, PHELAN, D, BURY, G, MULCAHY, F, CERVICAL SMEARS: COMPARISON OF KNOWLEDGE AND PRACTICE OF A GENERAL PRACTICE SAMPLE WITH A HIGH-RISK GROUP, INTERNATIONAL JOURNAL OF STD & AIDS, 12, 2001, p171 - 175
HOPKINS, S, LYONS, F, MULCAHY, F, BERGIN, C, THE GREAT PRETENDER RETURNS TO DUBLIN, IRELAND, SEXUALLY TRANSMITTED INFECTIONS, 77, 2001, p316 - 318
CLARKE, S, HARRINGTON, P, CONDON, C, KELLEHER, D, SMITH, OP, MULCAHY, F, LATE ONSET HEPATITIS AND PROLONGED DETERIORATION IN HEPATIC FUNCTION ASSOCIATED WITH NEVIRAPINE THERAPY, INTERNATIONAL JOURNAL OF STD & AIDS, 11, 2000, p336 - 337
CLARKE, SM, MULCAHY, F, HEALY, CM, CONDON, S, BUTLER, KM, THE EFFICACY AND TOLERABILITY OF COMBINATION ANTIRETROVIRAL THERAPY IN PREGNANCY: INFANT AND MATERNAL OUTCOME, INTERNATIONAL JOURNAL OF STD & AIDS, 11, 2000, p220 - 223
BLAXHULT, A, KIRK, O, PEDERSEN, C, DIETRICH, M, BARTON, SE, GATELL, JM, MULCAHY, F, HIRSCHEL, B, MOCROFT, A, LUNDGREN, JD, AIDS EUROPE STUDY GRP, REGIONAL DIFFERENCES IN PRESENTATION OF AIDS IN EUROPE, EPIDEMIOLOGY AND INFECTION, 125, 2000, p143 - 151
CLARKE, S, HARRINGTON, P, BARRY, M, MULCAHY, F, THE TOLERABILITY OF EFAVIRENZ AFTER NEVIRAPINE-RELATED ADVERSE EVENTS, CLINICAL INFECTIOUS DISEASES, 31, 2000, p806 - 807
MOCROFT, A, KATLAMA, C, JOHNSON, AM, PRADIER, C, ANTUNES, F, MULCAHY, F, CHIESI, A, PHILLIPS, AN, KIRK, O, LUNDGREN, JD, EUROSIDA STUDY GRP, AIDS ACROSS EUROPE, 1994-98: THE EUROSIDA STUDY, LANCET, 356, 2000, p291 - 296
MERRY, C, BARRY, MG, RYAN, M, TJIA, JF, HENNESSY, M, EAGLING, VA, MULCAHY, F, BACK, DJ, INTERACTION OF SILDENAFIL AND INDINAVIR WHEN CO-ADMINISTERED TO HIV-POSITIVE PATIENTS, AIDS, 13, 1999, pF101 - F107
EGAN, JF, OLEARY, B, LEWIS, MJ, MULCAHY, F, SHEEHY, N, HASEGAWA, H, FITZPATRICK, F, OCONNOR, JJ, ORIORDAN, J, HALL, WW, HIGH RATE OF HUMAN T LYMPHOTROPIC VIRUS TYPE IIA INFECTION IN HIV TYPE 1-INFECTED INTRAVENOUS DRUG ABUSERS IN IRELAND, AIDS RESEARCH AND HUMAN RETROVIRUSES, 15, 1999, p699 - 705
HUTCHINSON, S, COURTNEY, R, MULCAHY, F, OCONNOR, M, MULLANEY, S, KILBRIDE, R, MONITORING CYTOMEGALOVIRUS RETINITIS PREVALENCE IN AN HIV-SEROPOSITIVE COHORT: THE ASSESSMENT OF IMPROVEMENTS OBSERVED FOLLOWING THE INTRODUCTION OF HIGHLY ACTIVE ANTIRETROVIRAL TRIPLE THERAPY, INTERNATIONAL JOURNAL OF STD & AIDS, 10, 1999, p652 - 656
CLARKE, S, MULCAHY, F, USE OF ANTIRETROVIRAL AGENTS IN THE TREATMENT OF HIV INFECTION, 1998, -
ORMOND, P, MULCAHY, F, SEXUALLY TRANSMITTED DISEASES IN HIV-POSITIVE PATIENTS, DERMATOLOGIC CLINICS, 16, 1998, p853 - +
MERRY, C, MCMAHON, C, RYAN, M, OSHEA, E, MULCAHY, F, SMITH, OP, SUCCESSFUL USE OF PROTEASE INHIBITORS IN HIV-INFECTED HAEMOPHILIA PATIENTS, BRITISH JOURNAL OF HAEMATOLOGY, 101, 1998, p475 - 479
MERRY, C, BARRY, MG, MULCAHY, F, TJIA, JF, HALIFAX, KL, HEAVEY, J, KELLY, C, BACK, DJ, RITONAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH SAQUINAVIR IN HIV-INFECTED PATIENTS, AIDS, 12, 1998, 325 - 327
FLANAGAN, N, KANE, D, SWEENEY, E, MULCAHY, F, BARNES, L, CRUSTED SCARRING PLAQUES ON THE UPPER PART OF THE BACK, ARCHIVES OF DERMATOLOGY, 134, 1998, p366 - +
MERRY, C, BARRY, MG, MULCAHY, F, RYAN, M, TJIA, JF, HALIFAX, KL, BRECKENRIDGE, AM, BACK, DJ, THE PHARMACOKINETICS OF COMBINATION THERAPY WITH NELFINAVIR PLUS NEVIRAPINE, AIDS, 12, 1998, p1163 - 1167
BARRY, MG, MERRY, C, LLOYD, J, HALIFAX, K, CAREY, P, MULCAHY, F, BACK, DJ, VARIABILITY IN TROUGH PLASMA SAQUINAVIR CONCENTRATIONS IN HIV PATIENTS - A CASE FOR THERAPEUTIC DRUG MONITORING, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 45, 1998, 501 - 502
MCDONNELL, RJ, MCDONNELL, PM, ONEILL, M, MULCAHY, F, HEALTH RISK PROFILE OF PROSTITUTES IN DUBLIN, INTERNATIONAL JOURNAL OF STD & AIDS, 9, 1998, p485 - 488
BARRY, M, BACK, DJ, ANTIRETROVIRAL THERAPY FOR PATIENTS WITH HIV DISEASE, by MULCAHY, F , BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 45, 1998, p221 - 228
MULCAHY, F, BARRY, M, MERRY, C, BACK, D, NELFINAVIR AND NEVIRAPINE INTERACTION?, AIDS, 12, 1998, 2361 - 2361
KANE, D, KEATING, S, MCCANN, S, MULCAHY, F, THE MANAGEMENT OF ACUTE MYELOID LEUKAEMIA (AML) IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION: A CASE REPORT AND REVIEW, INTERNATIONAL JOURNAL OF STD & AIDS, 8, 1997, p272 - 274
KERR, JR, KANE, D, CROWLEY, B, LEONARD, N, OBRIAIN, S, COYLE, PV, MULCAHY, F, PARVOVIRUS B19 INFECTION IN AIDS PATIENTS, INTERNATIONAL JOURNAL OF STD & AIDS, 8, 1997, p184 - 186
BALSLEV, U, MONFORTE, AD, STERGIOU, G, ANTUNES, F, MULCAHY, F, PEHRSON, PO, PHILLIPS, A, PEDERSEN, C, LUNDGREN, JD, INFLUENCE OF AGE ON RATES OF NEW AIDS-DEFINING DISEASES AND SURVIVAL IN 6546 AIDS PATIENTS, SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 29, 1997, p337 - 343
BARRY, M, BACK, D, MULCAHY, F, PROTEASE INHIBITORS IN PATIENTS WITH HIV DISEASE - CLINICALLY IMPORTANT PHARMACOKINETIC CONSIDERATIONS, by GIBBONS, S , CLINICAL PHARMACOKINETICS, 32, 1997, p194 - 209
MERRY, C, BARRY, MG, MULCAHY, F, HALIFAX, KL, BACK, DJ, SAQUINAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH NELFINAVIR IN HIV-INFECTED PATIENTS, AIDS, 11, 1997, pF117 - F120
OCONNOR, WJ, MURPHY, GM, DARBY, C, FOGARTY, J, MULCAHY, F, OMOORE, R, BARNES, L, PORPHYRIN ABNORMALITIES IN ACQUIRED IMMUNODEFICIENCY SYNDROME, ARCHIVES OF DERMATOLOGY, 132, 1997, p1443 - 1447
MERRY, C, MULCAHY, F, BARRY, M, GIBBONS, S, BACK, D, SAQUINAVIR INTERACTION WITH MIDAZOLAM: PHARMACOKINETIC CONSIDERATIONS WHEN PRESCRIBING PROTEASE INHIBITORS FOR PATIENTS WITH HIV DISEASE, AIDS, 11, 1997, 268 - 269
MERRY, C, BARRY, MG, MULCAHY, F, RYAN, M, HEAVEY, J, TJIA, JF, GIBBONS, SE, BRECKENRIDGE, AM, BACK, DJ, SAQUINAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH RITONAVIR IN HIV-INFECTED PATIENTS, AIDS, 11, 1997, pF29 - F33
BERGIN, C, OREILLY, M, GOH, J, ONEILL, D, MULCAHY, F, SEXUALLY TRANSMITTED DISEASES IN THE ELDERLY? A REALITY - REPLY, JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 8, 1997, 73 - 73
OREILLY, M, BERGIN, C, MULCAHY, F, AIDS-RELATED MALIGNANCIES IN IRELAND 1987-1994, JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 8, 1997, p116 - 120
LEONARD, N, MCCREARY, C, FLINT, SF, MABRUK, MJEMF, MULCAHY, F, TONER, M, AUTOPSY FINDINGS IN THE TONGUES OF 20 PATIENTS WITH AIDS, JOURNAL OF ORAL PATHOLOGY & MEDICINE, 26, 1997, p244 - 247
BROWN, AJL, LOBIDEL, D, WADE, CM, REBUS, S, PHILLIPS, AN, BRETTLE, RP, FRANCE, AJ, LEEN, CS, MCMENAMIN, J, MCMILLAN, A, MAW, RD, MULCAHY, F, ROBERTSON, JR, SANKAR, KN, SCOTT, G, WYLD, R, PEUTHERER, JF, THE MOLECULAR EPIDEMIOLOGY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 IN SIX CITIES IN BRITAIN AND IRELAND, VIROLOGY, 235, 1997, p166 - 177
ODONOVAN, ML, FITZPATRICK, F, MULCAHY, F, GAFFNEY, EF, CALCIFYING PNEUMOCYSTIS CARINII THYROIDITIS, INTERNATIONAL JOURNAL OF STD & AIDS, 8, 1997, p652 - 654
PEDERSEN, C, DANNER, S, LAZZARIN, A, GLAUSER, MP, WEBER, R, KATLAMA, C, BARTON, SE, LUNDGREN, JD, CLUMECK, N, DEWIT, S, SOMMEREIJNS, B, NIELSEN, JO, NIELSEN, T, JENSEN, G, SKINHOJ, P, BENTSEN, K, GERSTOFT, J, MELBYE, M, RANKI, A, VALLE, SL, BERLUREAU, P, DIETRICH, M, SCHWANDER, S, GOEBEL, FD, KOSMIDIS, J, STERGIOU, G, GOUZIA, T, PAPADOPOULOS, A, BANHEGYI, D, MULCAHY, F, YUST, I, BENISHAI, Z, BENTWICH, Z, SACKS, T, MAAYAN, S, VELLA, S, CHIESI, A, ANCARANI, F, SCALISE, G, BERTAGGIA, A, FRANCAVILLA, E, CALONGHI, G, EMILIA, R, CARGNEL, A, ARLOTTI, M, CIAMMARUGHI, R, RIMINI, I, COLOMBA, A, DELALLA, F, FASSIO, P, FERLINI, A, FIACCADORI, F, PASETTI, G, GIANNELLI, F, GRILLONE, W, MONFORTE, AD, MIGNANI, E, ANDREA, S, NUNNARI, A, ORTONA, L, PANICHI, G, PAULUZZI, S, PIERSANTELLI, N, RANIERI, S, RICCIARDIELLO, P, ROSCIOLI, B, SORANZO, M, HEMMER, R, REISS, P, ANTUNES, F, GONZALEZLAHOZ, J, POLO, R, CLOTET, B, GATELL, J, BUIRA, E, MIRO, J, PEHRSON, P, LUTHY, R, LEDERGERBER, B, OLSSON, C, GLAUSER, M, HIRSCHEL, B, JOHNSON, A, HAWKES, S, PHILLIPS, A, BARTON, S, MORCINEK, J, PINCHING, A, COLEMAN, D, GJORUP, I, NIEPORT, C, TEGLBJAERG, L, THORNVAL, A, EPIDEMIOLOGY OF CRYPTOSPORIDIOSIS AMONG EUROPEAN AIDS PATIENTS, GENITOURINARY MEDICINE, 72, 1996, p128 - 131
MERRY, C, TOLERABILITY OF RITONAVIR AND SAQUINAVIR DURING TRIPLE THERAPY FOR HIV INFECTION, unknown, 1996, 10, ISI Web of Science, 1996, ppP22 - P22
BERGIN, CJ, WALLIS, F, OLEARY, A, OREILLY, M, MOLLOY, M, MULCAHY, F, DAY CASE INSERTION OF HICKMAN LINES IN HIV POSITIVE PATIENTS IN A RADIOLOGICAL UNIT, INTERNATIONAL JOURNAL OF STD & AIDS, 7, 1996, 380 - 382
MERRY, C, ALPHA(1)-ACID GLYCOPROTEIN CONCENTRATION IN HIV DISEASE - IMPLICATIONS FOR TREATMENT WITH PROTEASE INHIBITORS, unknown, 1996, 10, ISI Web of Science, 1996, ppP21 - P21
MERRY, C, SAQUINAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH RITONAVIR IN PATIENTS WITH HIV DISEASE., unknown, 1996, 10, ISI Web of Science, 1996, ppOP61 - OP61
LANDERS, D, BERGIN, C, OLEARY, A, MERRY, C, KEATING, S, MULCAHY, F, DAPSONE INDUCED METHAEMOGLOBINAEMIA, INTERNATIONAL JOURNAL OF STD & AIDS, 7, 1996, p445 - 447
MURPHY, DJ, MULCAHY, F, TRANSMISSION OF HIV, LANCET, 345, 1995, 988 - 988
BERGIN, C, OLEARY, A, MCCREARY, C, SABRA, K, MULCAHY, F, TREATMENT OF KAPOSIS-SARCOMA WITH LIPOSOMAL DOXORUBICIN, AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 52, 1995, p2001 - 2004
MCCREARY, C, BERGIN, C, PILKINGTON, R, KELLY, G, MULCAHY, F, CLINICAL-PARAMETERS ASSOCIATED WITH RECALCITRANT ORAL CANDIDOSIS IN HIV-INFECTION - A PRELIMINARY-STUDY, INTERNATIONAL JOURNAL OF STD & AIDS, 6, 1995, 204 - 207
LUNDGREN, JD, BARTON, SE, LAZZARIN, A, DANNER, S, GOEBEL, FD, PEHRSON, P, MULCAHY, F, KOSMIDIS, J, PEDERSEN, C, PHILLIPS, AN, CLUMECK, N, DEWIT, S, SOMMEREIJNS, B, NIELSEN, JO, LUNDGREN, J, NIELSEN, T, JENSEN, G, SKINHOJ, P, BENTSEN, K, GERSTOFT, J, MELBYE, M, RANKI, A, VALLE, SL, KATLAMA, C, BERLUREAU, P, DIETRICH, M, SCHWANDER, S, PAPADOPOULOS, A, BANHEGYI, D, YUST, I, BENISHAI, Z, BENTWICH, Z, SACKS, T, MAAYAN, S, VELLA, S, CHIESI, A, ANCARANI, F, SCALISE, G, BERTAGGIA, A, FRANCAVILLA, E, CALONGHI, G, CARGNEL, A, ARLOTTI, M, CIAMMARUGHI, R, COLOMBA, A, DELALLA, F, FASSIO, P, FERLINI, A, FIACCADORI, F, PASETTI, G, GIANNELLI, F, GRILLONE, W, DARMINIO, A, SACCO, L, MIGNANI, E, NUNNARI, A, ORTONA, L, PANICHI, G, PAULUZZI, S, PIERSANTELLI, N, RANIERI, S, RICCIARDIELLO, P, ROSCIOLI, B, SORANZO, M, HEMMER, R, BLOEMKOLK, D, ANTUNES, F, PROENCA, R, GONZALEZLAHOZ, J, MARTINEZBLANCO, L, CLOTET, B, GATELL, J, BUIRA, E, MIRO, J, LUTHY, R, LEDERGERBER, B, OLSSON, C, GLAUSER, M, HIRSCHEL, B, JOHNSON, A, HAWKES, S, PHILLIPS, A, BARTON, S, MORCINEK, J, PINCHING, A, COLEMAN, D, GJORUP, I, NIELSEN, J, NIEPORT, C, TEGLBJAERG, L, THORNVAL, A, FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN 5,025 EUROPEAN PATIENTS WITH AIDS, CLINICAL INFECTIOUS DISEASES, 21, 1995, p106 - 113
LYONS, DJ, OMAHONEY, P, KEATING, J, MULCAHY, F, CLANCY, L, TUBERCULIN SKIN TESTING AND THE DEVELOPMENT OF TUBERCULOSIS IN A COHORT OF HIV-INFECTED INDIVIDUALS, IRISH MEDICAL JOURNAL, 87, 1995, p108 - 110
MULCAHY, F, KELLY, G, TYNAN, M, THE NATURAL-HISTORY OF HIV-INFECTION IN WOMEN ATTENDING A SEXUALLY-TRANSMITTED DISEASE CLINIC IN DUBLIN, GENITOURINARY MEDICINE, 70, 1994, p81 - 83
LUNDGREN, JD, PEDERSEN, C, CLUMECK, N, GATELL, JM, JOHNSON, AM, LEDERGERBER, B, VELLA, S, PHILLIPS, A, NIELSEN, JO, DEWIT, S, SOMMEREIJNS, B, NIELSEN, T, JENSEN, G, SKINHOJ, P, BENTSEN, K, GERSTOFT, J, MELBYE, M, RANKI, A, VALLE, SL, KATLAMA, C, BERLUREAU, P, DIETRICH, M, SCHWANDER, S, GOEBEL, FD, KOSMIDIS, J, STERGIOU, G, GOUZIA, T, PAPADOPOULOS, A, BANHEGYI, D, MULCAHY, F, YUST, I, BENISHAI, Z, BENTWICH, Z, SACKS, T, MAAYAN, S, CHIESI, A, ANCARANI, F, SCALISE, G, BERTAGGIA, A, FRANCAVILLA, E, CALONGHI, G, CARGNEL, A, ARLOTTI, M, CIAMMARUGHI, R, COLOMBA, A, DELALLA, F, FASSIO, P, FERLINI, A, FIACCADORI, F, PASETTI, G, GIANNELLI, F, GRILLONE, W, LAZZARIN, A, MONFORTE, AD, MIGNANI, E, NUNNARI, A, ORTONA, L, PANICHI, G, PAULUZZI, S, PIERSANTELLI, N, RANIERI, S, RICCIARDIELLO, P, ROSCIOLI, B, SORANZO, M, HEMMER, R, DANNER, S, ANTUNES, F, PROENCA, R, GONZALEZLAHOZ, J, MARTINEZBLANCO, L, CLOTET, B, BUIRA, E, MIRO, J, PEHRSON, P, LUTHY, R, OLSSON, C, GLAUSER, M, HIRSCHEL, B, HAWKES, S, BARTON, S, MORCINEK, J, PINCHING, A, COLEMAN, D, SURVIVAL DIFFERENCES IN EUROPEAN PATIENTS WITH AIDS, 1979-89, BRITISH MEDICAL JOURNAL, 308, 1994, p1068 - 1073
MURPHY, D, LYNCH, M, MULCAHY, F, ZIDOVUDINE RELATED ARTHROPATHY, BRITISH MEDICAL JOURNAL, 309, 1994, 97 - 97
MULCAHY, F, HIV, AIDS, AND THE BRAIN - ASSOCIATION FOR RESEARCH IN NERVOUS AND MENTAL DISEASE, VOL 72 - PRICE,RW, PERRY,SW, IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 11, 1994, 102 - 102
BERGIN, C, PILKINGTON, R, MCCREARY, C, MULCAHY, F, CROWLEY, V, LACTIC-ACIDOSIS, NON-HODGKINS-LYMPHOMA AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, GENITOURINARY MEDICINE, 70, 1994, 148 - 149
LUNDGREN, JD, PHILLIPS, AN, PEDERSEN, C, CLUMECK, N, GATELL, JM, JOHNSON, AM, LEDERGERBER, B, VELLA, S, NIELSEN, JO, DEWIT, S, SOMMEREIJNS, B, NIELSEN, T, JENSEN, G, SKINHOJ, P, BENTSEN, K, GERSTOFT, J, MELBYE, M, RANKI, A, VALLE, SL, KATLAMA, C, BERLUREAU, P, DIETRICH, M, SCHWANDER, S, GOEBEL, FD, KOSMIDIS, J, STERGIOU, G, GOUZIA, T, PAPADOPOULOS, A, BANHEGYI, D, MULCAHY, F, YUST, I, BENISHAI, Z, BENTWICH, Z, SACKS, T, MAAYAN, S, CHIESI, A, ANCARANI, F, SCALISE, G, BERTAGGIA, A, FRANCAVILLA, E, CALONGHI, G, CARGNEL, A, ARLOTTI, M, CIAMMARUGHI, R, COLOMBA, A, DELALLA, F, FASSIO, P, FERLINI, A, FIACCADORI, F, PASETTI, G, GIANNELLI, F, GRILLONE, W, LAZZARIN, A, MONFORTE, AD, MIGNANI, E, NUNNARI, A, ORTONA, L, PANICHI, G, PAULUZZI, S, PIERSANTELLI, N, RANIERI, S, RICCIARDIELLO, P, ROSCIOLI, B, SORANZO, M, HEMMER, R, DANNER, S, BLOEMKOLK, D, ANTUNES, F, PROENCA, R, GONZALEZLAHOZ, J, MARTINEZBLANCO, L, CLOTET, B, GATELL, J, BUIRA, E, MIRO, J, PEHRSON, P, LUTHY, R, LEDERGERBER, B, OLSSON, K, GLAUSER, M, HIRSCHEL, B, JOHNSON, A, HAWKES, S, PHILLIPS, A, BARTON, S, MORCINEK, J, PINCHING, A, COLEMAN, D, GJPRUP, I, NIELSEN, J, NIEPORT, C, TEGLBJAERG, L, THORNVAL, A, COMPARISON OF LONG-TERM PROGNOSIS OF PATIENTS WITH AIDS TREATED AND NOT TREATED WITH ZIDOVUDINE, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 271, 1994, p1088 - 1092
BARRY, M, HOWE, JL, ORMESHER, S, BACK, DJ, BRECKENRIDGE, AM, BERGIN, C, MULCAHY, F, BEECHING, N, NYE, F, PHARMACOKINETICS OF ZIDOVUDINE AND DIDEOXYINOSINE ALONE AND IN COMBINATION IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 37, 1994, p421 - 426
MURPHY, M, MULCAHY, F, FOURNIER GANGRENE AND HIV DISEASE, GENITOURINARY MEDICINE, 69, 1993, 326 - 326
CHARTHAIGH, MN, CROWLEY, B, LYNCH, M, MULCAHY, F, SUCCESSFUL TREATMENT OF CUTANEOUS CYTOMEGALOVIRUS, INTERNATIONAL JOURNAL OF STD & AIDS, 4, 1993, p52 - 53
TRIMBLE, KC, GOGGINS, MG, MOLLOY, AM, MULCAHY, F, SCOTT, JM, WEIR, DG, VITAMIN-B12 DEFICIENCY IS NOT A CAUSE OF HIV-ASSOCIATED NEUROPATHY, AIDS, 7, 1993, 1132 - 1133
SULLIVAN, D, BENNETT, D, HENMAN, M, HARWOOD, P, FLINT, S, MULCAHY, F, SHANLEY, D, COLEMAN, D, OLIGONUCLEOTIDE FINGERPRINTING OF ISOLATES OF CANDIDA SPECIES OTHER THAN CANDIDA-ALBICANS AND OF ATYPICAL CANDIDA SPECIES FROM HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE AND AIDS PATIENTS, JOURNAL OF CLINICAL MICROBIOLOGY, 31, 1993, p2124 - 2133
HEALY, E, MEENAN, J, MULCAHY, F, BARNES, L, THE SPECTRUM OF HIV-RELATED SKIN DISEASES IN AN IRISH POPULATION, IRISH MEDICAL JOURNAL, 86, 1993, p188 - 190
DOWLING, S, LAMBE, J, MULCAHY, F, VITAMIN-B12 AND FOLATE STATUS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, EUROPEAN JOURNAL OF CLINICAL NUTRITION, 47, 1993, p803 - 807
MACLEOD, D, KANE, B, KIDNEY, D, MURPHY, J, OBRIAIN, DS, JACKSON, F, MULVIHILL, B, MULCAHY, F, CLANCY, L, PRICHARD, JS, A CLINICOPATHOLOGICAL STUDY OF 79 BRONCHOSCOPIES IN HIV-POSITIVE PATIENTS, IRISH MEDICAL JOURNAL, 86, 1993, 167 - 169
DOWLING, S, MULCAHY, F, GIBNEY, MJ, NUTRITION IN THE MANAGEMENT OF HIV ANTIBODY POSITIVE PATIENTS - A LONGITUDINAL-STUDY OF DIETETIC OUTPATIENT ADVICE, EUROPEAN JOURNAL OF CLINICAL NUTRITION, 44, 1991, p823 - 829
KEATING, JN, TRIMBLE, KC, MULCAHY, F, SCOTT, JM, WEIR, DG, EVIDENCE OF BRAIN METHYLTRANSFERASE INHIBITION AND EARLY BRAIN INVOLVEMENT IN HIV-POSITIVE PATIENTS, LANCET, 337, 1991, p935 - 939
OBRIAIN, DS, JACKSON, F, COURTNEY, MG, OMALLEY, F, MCDONALD, GS, MULVIHILL, EM, DINN, JJ, TEMPERLEY, IJ, MULCAHY, F, THE EMERGING AIDS EPIDEMIC IN IRELAND - CLINICOPATHOLOGICAL FINDINGS IN 23 EARLY CASES, IRISH MEDICAL JOURNAL, 83, 1990, p50 - 53
MCLOUGHLIN, P, MULCAHY, F, OBRIAIN, DS, KANE, B, MULVIHILL, E, PRICHARD, JS, LUNG PATHOLOGY IN HIV POSITIVE PATIENTS, IRISH MEDICAL JOURNAL, 83, 1990, p109 - 111
BARRY, M, THE EFFECT OF AZIDOTHYMIDINE (AZT) ON OXIDATIVE DRUG-METABOLISM IN PATIENTS WITH AIDS, unknown, 1989, 27, ISI Web of Science, 1989, ppP667 - P668
BARRY, M, AZIDOTHYMIDINE (AZT) AND HEPATIC DRUG-METABOLISM, unknown, 1988, 95, ISI Web of Science, 1988, ppP614 - P614
MULCAHY, F, RISK OF AIDS TO HEALTH-CARE WORKERS - REPLY, IRISH MEDICAL JOURNAL, 80, 1987, 296 - 296
MULCAHY, F, MARSHALL, EJ, BAKSHI, M, MCMAHON, B, WALSH, M, TORSADE-DE-POINTES - 2 CASE-REPORTS, IRISH JOURNAL OF MEDICAL SCIENCE, 151, 1983, 393 - 394
Non-Peer-Reviewed Publications
EuroSIDA study Group includes Dr Fiona Mulcahy, Changing Incidence of central nervous system diseases in EuroSIDA cohort, American Neurological Association, 2004
M Hennessy, F Mulcahy, P Spiers, S Hospkins, P Hoggard, S Kewn, D Back, C Bergin, Differential effects of Combined Pegylated Interferon and Ribavirin Therapy? On intracellular Nucleotide Triphosphate levels in HIV/HCV coinfected patients: a potential mechanism for enhanced toxicity, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004
Mulcahy F, Co-infection with syphilis: natural history and management, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004
F.Lyons, E. Devitt, S. Hopkins, F. Mulcahy F, Sequential pregnancies in HIV infected women, BASHH/ASTDA Spring Meeting, Bath, UK, 19-21 May, 2004
F. Lyons, S. Coughlan, C. Byrne, S. Hopkins, Wm. Hall, C. Bergin and F. Mulcahy, Emergence of genotypic resistance in HIV-1 infected pregnant women taking highly antiretroviral therapy to reduce mother-to-child transmission of HIV-1, Poster 892, 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, February, 2004
Chew N, Brannigan E, Lynch R, Mulcahy F, Bergin C., HIV tuberculosis coninfection. Changing prevalence and impact on antiretroviral use, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004
Results from the EuroSida Study Group. (includes Mulcahy F), Changes in hospital admission across Europe: 1995 - 2003, HIV Medicine, 5, 2004, p437 - 447
Holmes A, McCullagh L, Bergin C, Mulcahy F, Long term follow up of a cohort of antiretroviral experienced HIV-1 infected pateitns simplified to Trizivir, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004
E Devitt, S Hopkins, F Mulcahy, C Bergin, Rising number os HIV infection after a syphilis epidemic, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004
DAD study. (Includes Mulcahy F) , Cardio and cerebrovascular events and predicted rates of mycocardial infarction, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004
DAD study (Includes Mulcahy F), Predictors of hypertension and changes in blood pressure in HIV infected patients, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004
Moriarty M, McCullagh L, Sabra K, Bergin C, Mulcahy F., A complete drug history should be sought, 7th International Congress on Drug Therapy in HIV Infection, Glasgow, UK, 14-18 Nov, 2004
S Hopkins, A Khalid, G Courtney, F Mulcahy, C Bergin, Syphilis treatment outcomes in HIV infected and non-infected individuals, 11th Conference on Retroviruses and Opportunistic Infections, February, 2004
Mulcahy F, The effectiveness of partner notification for gonococcal infection: A comparison between men who have sex with men ( MSM) and heterosexual males, BASHH/ASTDA Spring Meeting, Bath UK, 19-21 May, 2004
S. Hopkins, F. Lyons, E. Brannigan, F. Mulcahy, C. Bergin, Pegylated Interferon and Ribavirin in HIV-HCV Coinfected Patients (Oral Presentation), British Infection Society, 6th Annual Scientific Meeting, London, 2003
S Hopkins, H McDermott, F Lyons, C Bergin and F Mulcahy, Syphilis and the central nervous system (CNS) in HIV infected patients, 2nd IAS Conference on HIV pathogenesis and treatment, Paris, 2003
F. Lyons, S. Hopkins, A. Mc Geary, G. Sheehan, C. Bergin, and F. Mulcahy, Nevirapine tolerability in HIV infected women in pregnancy - A word of caution, Late breaker 27, 2nd IAS conference on HIV pathogenesis and treatment, Paris, France, July, 2003
S. Hopkins, E. Brannigan, F. Lyons, H. McDermott, F. Mulcahy, C. Bergin, The Impact of treatment with Pegylated Interferon and Ribavirin on ART Prescribing in HIV-HCV Coinfected Patients. (Oral Presentation), Clinical Microbiology & Infection, 13th European Congress of Clinical Microbiology & Infectious Diseases, Glasgow, 9, (Supplement 1), 2003, pp52-O281
S. Hopkins, G. Farrell, F. Mulcahy. C. Bergin, HIV-HCV Coinfection : To Treat or Not to Treat, Antiviral Therapy, 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, Paris, 8, (Supplement 1), 2003, ppS458 - 459
F Lyons, S Hopkins, C Bergin and F Mulcahy, Maternal tolerability of antiretroviral therapy (art) in preventing vertical transmission (vt) of HIV-1, 9th European AIDS Conference, Warsaw, Poland, October, 2003
S. Hopkins, L. Thornton, M. Fitzgerald, C. Merry, C. Bergin, F. Mulcahy, Case Finding Strategies in a Syphilis Outbreak, Clinical Microbiology & Infection, 13th European Congress of Clinical Microbiology & Infectious Diseases, Glasgow, 9, (Supplement 1), 2003, pp277 - P1171
E. Brannigan, S. Hopkins, P. Coakley, F. Mulcahy, C. Bergin, Impact of Migration on the Prevalence of Mycobacterial Infections in HIV-postive Patients in Ireland, 13th European Congress of Clinical Microbiology & Infectious Diseases, Glasgow, 2003
MURPHY, N, P16INK4A, CDC6, MCM5 AND HPV STATUS: PREDICTIVE BIOMARKERS OF CERVICAL PRE-NEOPLASIA?, unknown, 2002, 198, ISI Web of Science, 2002, pp16A - 16A
HENNESSY, M, INTRACELLULAR INDINAVIR PHARMACOKINETICS IN HIV POSITIVE PATIENTS, 2000, 14, ISI Web of Science, 2001, ppS97 - S97
HENNESSY, M, ST JOHN'S WORT MODULATES BOTH EXPRESSION AND FUNCTION OF P GLYCOPROTEIN IN PERIPHERAL BLOOD LYMPHOCYTES, 2000, 14, ISI Web of Science, 2001, ppS95 - S95
CLARKE, S, ANALYSING LIMITING FACTORS IN THE ACCEPTANCE OF HAART IN INJECTION DRUG USERS (IDUS), 2000, 14, ISI Web of Science, 2001, ppS45 - S45
RYAN, M, CHANGING DEMOGRAPHICS OF AN IRISH HIV-INFECTED COHORT FROM 1995 TO 1999, 2000, 14, ISI Web of Science, 2001, ppS137 - S137
MULCAHY, F, ANTIVIRAL THERAPY AND MANAGEMENT OF HIV IN INTRAVENOUS DRUG USERS, 2000, 14, ISI Web of Science, 2001, ppS2 - S2
CLARKE, S, THE PHARMACOKINETIC INTERACTION BETWEEN METHADONE AND NELFINAVIR, 2000, 14, ISI Web of Science, 2001, ppS95 - S95
MILLER, V, LOVEDAY, C, STASZEWSKI, S, LUNDGREN, J, YOULE, M, AIT-KHALED, M, BOUCHER, C, BRUN-VEZINET, F, DEDES, N, GIAQUINTO, C, HERTOGS, K, HOUYEZ, F, PERRIN, L, PILLAY, D, SCHMIT, JC, SCHUURMAN, R, LANGE, J, BANHEGYI, D, BIONDI, G, BROEKHUIZEN, A, BUSH-DONOVAN, C, CAMACHO, R, CARLIER, H, CLAVEL, F, CLOTET, B, CLUMECK, N, COLEBUNDERS, R, DE CLERQ, K, DE JAEGHER, JJ, DE SCHRIJVER, G, DE SMET, K, HALL, W, HARRIGAN, R, HATZAKIS, A, HELLMANN, N, HOETELMANS, R, HOLTZER, C, KATLAMA, C, LARDER, D, LORIAUX, E, MCCREEDY, B, MULCAHY, F, OPRAVIL, M, PHILLIPS, A, RUIZ, N, SHULSE, E, SONNERBORG, A, SORIANO, V, STEEL, H, VELLA, S, WILLIAMS, A, CLINICAL AND LABORATORY GUIDELINES FOR THE USE OF HIV-1 DRUG RESISTANCE TESTING AS PART OF TREATMENT MANAGEMENT: RECOMMENDATIONS FOR THE EUROPEAN SETTING, by VANDAMME, AM , AIDS, 15, 2001
The Initio Co-Ordinating Committee, ( includes Mulcahy F), An open-label randomised trial to evaluate different therapeutic strategies of combination therapy in HIV-1 Infection: Design, Rationale and methods of the Initio trial, Controlled Clinical Trials, 22, (2), 2001
MCMAHON, C, COCAINE-INDUCED THROMBOCYTOPENIA IN A YOUNG HIV SEROPOSITIVE INJECTING DRUG USER, 2000, 14, ISI Web of Science, 2001, ppS67 - S67
CLARKE, SM, AN OUTBREAK OF SERIOUS UNEXPLAINED ILLNESS IN INJECTING DRUG USERS IN EUROPE - THE EXPERIENCE OF AN IRISH INSTITUTION, 2001, 33, ISI Web of Science, 2001, pp1119 - 1119
RYAN, M, DETERMINING THE COST OF HOSPITALISATION OF HIV-INFECTED PATIENTS IN IRELAND IN ORDER TO ASSESS THE PHARMACOECONOMIC IMPACT OF HAART ON INPATIENT CARE, 2000, 14, ISI Web of Science, 2001, ppS101 - S101
HARRINGTON, P, EFFICACY AND TOLERABILITY OF HYDROXYUREA CONTAINING SALVAGE ANTIRETROVIRAL REGIMENS IN THE MANAGEMENT OF HIV INFECTION, 2000, 14, ISI Web of Science, 2001, ppS35 - S35
MCGRATH, E, LIFE-SAVING CHEMOTHERAPY FOR KAPOSI'S SARCOMA IN A HIV POSITIVE PREGNANT WOMAN, 2000, 14, ISI Web of Science, 2001, ppS131 - S131
CLARKE, S, THE ACTIVE MANAGEMENT OF HIV IN PREGNANCY, 2000, 14, ISI Web of Science, 2001, ppS138 - S139
CURRAN, S, MYOCARDIAL INFARCTION AND PROTEASE INHIBITOR THERAPY: TWO CASE REPORTS, 2000, 14, ISI Web of Science, 2001, ppS62 - S62
COUGHLAN, S, CLINICAL UTILITY OF HIV-1 GENOTYPIC DRUG RESISTANCE TESTING IN A HETEROGENEOUS, NON-TRIAL POPULATION, 2000, 14, ISI Web of Science, 2001, ppS116 - S117
MURPHY, N, IMMUNOCYTOCHEMICAL ANALYSIS OF P16 PROTEIN EXPRESSION IN CERVICAL CANCER AND CERVICAL INTRAEPITHELIAL NEOPLASIA., 2001, 195, ISI Web of Science, 2001, pp2A - 2A
FAY, L, ERYTHRODYSETHESIA FOLLOWING DOXORUBICIN THERAPY FOR KAPOSI'S SARCOMA, 2000, 14, ISI Web of Science, 2001, ppS67 - S67
HOPKINS, S, HEPATITIS C: PREVALENCE AND IMPLICATIONS FOR TREATMENT IN THE HIV CO-INFECTED POPULATION, 2000, 14, ISI Web of Science, 2001, ppS125 - S125
CLARKE, S, MERRY, C, MORAN, AM, MULCAHY, F, PNEUMOCOCCAL PNEUMONIA ASSOCIATED WITH PERIANAL HERPES SIMPLEX VIRUS TYPE 2 IN A HIV SEROPOSITIVE PATIENT, 1999, -
BARRY, M, PHARMACOKINETICS AND POTENTIAL INTERACTIONS AMONGST ANTIRETROVIRAL AGENTS USED TO TREAT PATIENTS WITH HIV INFECTION, by MULCAHY, F , CLINICAL PHARMACOKINETICS, 36, 1999
BARRY, M, HYDROXYUREA-INDUCED NEUROTOXICITY IN HIV DISEASE, 1999, -
MERRY, C, AN OVERDOSE OF POST EXPOSURE PROPHYLAXIS IN A PREGNANT WOMAN., 1998, 12, ISI Web of Science, 1998, ppS57 - S57
BACK, D, INTERACTIONS BETWEEN ANTIRETROVIRALS, 1998, 12, ISI Web of Science, 1998, ppS6 - S6
CONDON, S, COMBINATION ANTIRETROVIRAL THERAPY (ART) IN PREGNANCY: INFANT OUTCOME, 1998, 12, ISI Web of Science, 1998, ppS94 - S94
MC MAHON, C, SUCCESSFUL USE OF PROTEASE INHIBITORS IN HIV-INFECTED PATIENTS WITH HAEMOPHILIA, 1998, 101, ISI Web of Science, 1998, pp87 - 87
BARRY, M, RITONAVIR INDUCED HYPERLIPIDAEMIA IN PATIENTS WITH HIV DISEASE, 1998, 12, ISI Web of Science, 1998, ppS52 - S52
Dr Fiona Mulcahy - Principal Investigator for St James Hospital, Dublin, A long term open-label rollover trial assessing the safety and tolerability of combination tipranavir and ritonavir use in HIV-1 infected subjects. (Resist 1182.17)
Dr Fiona Mulcahy - Principal Investigator for St James Hospital, Dublin, An open-label comparative study to evaluate the antiviral efficacy and safety of Nevirapine and Efavirenz or both drugs combined in combination with d4T and 3TC (2NN study)
Dr Fiona Mulcahy - Principal Investigator for St James Hospital, Dublin, An open label pharmacokinetic study to evaluate the interaction between Nevirapine and Methadone in HIV-1 infected, opoid-dependent adults on stable methadone maintenance therapy. (Methadone/Neviripine study)
Dr Fiona Mulcahy - Principal Investigator for St James Hospital, Dublin, A randomised, open label. phase III, international study of subcutaneous recombinant IL-2 (Proleukin) in patients with HIV-1 infection and CD4 cell counts > 300/mm3: Evaluation of Subcutaneous Proleukin in a randomised international trial (ESPRIT)
2NN Study Group includes Dr Fiona Mulcahy, Comparison of first-line antiretroviral therapy with regimens including Nevirapine, Efavirenz or both drugs, plus stavudine and lamivudine: a randomised open-label trail, the 2NN Study, The Lancet, 363, (9417)
Dr Fiona Mulcahy - Principal Investigator for St James Hospital, Dublin, A randomised open-label. comparative safety and efficacy study of tipranavir boosted with low dose ritonavir versus genotypically-defined protease inhibitor/ritonavir in multiple antiretroviral drug-experienced patients (Resist 2 1182.48)
Dr Fiona Mulcahy - Principal Investigator for St James Hospital, Dublin, A phase IV randomised open-label trial to evaluate the safety and efficacy of continued 3TC twice-daily therapy versus discontinuation of 3TC, as part of the second-line treatment of HIV-1 infection in patients who have shown virological failure on first-line combination treatments containing 3TC (Colate)
Research Expertise
Projects
- Title
- AIDS directed programme on HIV treatment.
- Summary
- i. Concorde: A double blind placebo controlled study to determine the efficacy of Zidovudine in reducing disease progression among patients with CDC Group II and III HIV infection, (Medical Research Council, UK).
ii. Alpha: A study of the efficacy and safety of 2,3 DDI in patients with HIV infection who are intolerant to Zidovudine (Medical Research Council, UK).
iii. Delta: A randomised double-blind trial to assess the efficacy and safety of combinations of AZT (Zidovudine 3-azido-3-deoxythymidine) DDI (Didanosine, 2,3-dideoxyinosine) and DDC (dideoxycytidine) in patients with Human Immune Virus (HIV) infection.
- i. Concorde: A double blind placebo controlled study to determine the efficacy of Zidovudine in reducing disease progression among patients with CDC Group II and III HIV infection, (Medical Research Council, UK).
- Funding Agency
- Co-grant holder of Medical Research Council (MRC)
- Date From
- 1988
- Date To
- 1998
- Title
- Collaborative Multicentre Study on HIV infection in women.
- Summary
- Co-grant holder investigator of MRC Collaborative Multicentre Study on HIV infection in women.
- Funding Agency
- MRC
- Date From
- 1994
- Date To
- 1997
- Title
- Study on Molecular Epidemiology of HIV infection
- Summary
- Co-investigator of MRC Study on Molecular Epidemiology of HIV infection
- Funding Agency
- MRC
- Date From
- 1993
- Date To
- 1997
- Title
- "An open randomised trial to evaluate different therapeutic strategies of combination therapy for HIV I infection"
- Summary
- Principal -investigator of INITIO Trial with Medical Research Council (MRC), London. .
- Funding Agency
- MRC
- Date From
- 1999
- Date To
- 2004
- Title
- COLATE (Continue On Lamividine Treatment in Europe)
- Summary
- Principal investigator of COLATE (Continue On Lamividine Treatment in Europe), Copenhagen HIV Programme (CHIP).
- Date From
- 1999
- Date To
- 2003
- Title
- "An evaluation of the benefits and risks of Isoniazid Chemoprophylaxis for Tuberculosis in individuals with HIV infection, considered to be at increased risk of developing Tuberculosis".
- Summary
- Co-investigator of Medical Research Council (MRC)
- Funding Agency
- MRC
- Date From
- 1999
- Title
- ESPIRIT (MRC/HIH) A phase III open label, randomised trial to compare the effects of subcutaneous recombinant interleukin 2 (SC rIL -2) on disease progression in patients who are receiving ART.
- Summary
- Principal investigator
- Date From
- 2001
- Date To
- to date
- Title
- Resist (Boehringer Ingelheim) Randomised evaluation of strategic intervention in multi drug resistant patients with Tipranavir.
- Summary
- Principal investigator
- Date From
- 2003
- Date To
- to date
- Title
- Resist roll-over (Boehringer Ingelheim) Access to Tipranavir for patients who were randomised to the PI?RTV arm with a lack of virologic response or confirmed virologic failure after eight weeks of treatment.
- Summary
- Principal investigator
- Date From
- 2003
- Date To
- to date
- Title
- OD + Methadone (Gilead) An open label multicentre study
- Summary
- Principal investigator - OD + Methadone (Gilead) An open label multicentre study to assess efficacy, tolerability and adherence of a once daily taken ART containing Tenofovir 300mgs in combination with the best suitable once daily regimen being 2 NRTI's or 1 NRTI plus 1 PI or 1 NRTI plus 1 NNRTI in HIV infected IVDU patients with opiate substitution being either ART naïve or with suppressed viral load and without a history of virological failure.
- Date From
- 2004
- Date To
- to date
- Title
- 2NN Extended Follow up.
- Summary
- Principal investigator - 2NN Extended Follow up. The objective is to compare the virological, immunological and clinical efficacy of the different arms in the 2NN study in patients who were still using randomised treatment at the end of the 2NN study (week 48)
- Date From
- 2004
- Date To
- to date
- Title
- Methadone/Neviripine study
- Summary
- Principle Investigator - An open label pharmacokinetic study to evaluate the interaction between Nevirapine and Methadone in HIV-1 infected, opoid-dependent adults on stable methadone maintenance therapy. Boehringer
- Date From
- 2002
- Date To
- 2003